Peptide Nucleic Acid as Therapeutic Agent


With a repeating N-(2-aminoethyl)-glycine peptide backbone coupled to purine and pyrimidine nucleobases via a linker, PNA are synthetic analogues of DNA. PNA-based technology has received a lot of interest as a viable method for gene modification due to the unique qualities of PNA, including resistance to enzymatic digestion, increased bio stability, and excellent hybridization affinity toward DNA and RNA. However, inadequate intracellular absorption presents a significant obstacle to the use of PNA. To improve PNA delivery and ensure that it reaches the appropriate spot, some solutions have been devised


    Related Conference of Peptide Nucleic Acid as Therapeutic Agent

    June 19-20, 2023

    5th International Conference on Nucleic Acids

    London, UK
    September 18-19, 2023

    5th International Conference on Biochemistry

    London, UK
    September 21-22, 2023

    19th World Congress on Structural Biology

    Paris, France
    September 21-22, 2023

    14th International Conference on Biofuels and Bioenergy

    Toronto, Canada
    October 30-31, 2023

    14th World Congress on Cell & Tissue Science

    Rome, Italy
    November 01-02, 2023

    19th International Conference on Metabolomics

    Rome, Italy

    Peptide Nucleic Acid as Therapeutic Agent Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in